Functional Eicosanoid Test and typing (FET) in acetylsalicylic acid intolerant patients with urticaria

Journal of Physiology and Pharmacology

Volumn 57, Issue SUPPL. 12, 2006, Pages 35-46

  Velten, Florian W ^a   Bayerl, C ^b   Baenkler, H W ^c   Schaefer, D ^c  

^a UNIVERSITY OF HEIDELBERG   (Germany)

^b DR HORST SCHMIDT KLINIKEN   (Germany)

^c UNIVERSITY HOSPITAL ERLANGEN   (Germany)

Author keywords

Aspirin intolerance; Eicosanoid pattern score; Prostaglandine leukotriene balance; Urticaria

Indexed keywords

ACETYLSALICYLIC ACID; ARACHIDONIC ACID; ICOSANOID; NEUROPEPTIDE; PEPTIDOLEUKOTRIENE; PROSTAGLANDIN;

ADULT; AGED; ALLERGY TEST; ANAPHYLAXIS; ANGIONEUROTIC EDEMA; ATOPY; BLOOD SAMPLING; CLINICAL ARTICLE; CONFERENCE PAPER; CONTROLLED STUDY; DELAYED HYPERSENSITIVITY; DRUG EFFECT; DRUG HYPERSENSITIVITY; DRUG RELEASE; DYSPNEA; ENZYME IMMUNOASSAY; FEMALE; FUNCTION TEST; HUMAN; IMMEDIATE TYPE HYPERSENSITIVITY; IN VITRO STUDY; MALE; SCORING SYSTEM; STEADY STATE; URTICARIA;

ADULT; AGED; ANAPHYLAXIS; ANGIOEDEMA; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; ASPIRIN; CASE-CONTROL STUDIES; DRUG HYPERSENSITIVITY; EICOSANOIDS; FEMALE; HUMANS; IMMUNOENZYME TECHNIQUES; LEUKOTRIENES; MALE; MIDDLE AGED; PROSTAGLANDINS; URTICARIA;

EID: 34147167573     PISSN: 08675910     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (20)

1. Gunnar RM, Passamani ER, Bourdillon PD, et al. Guidelines for the early management of patients with acute myocardial infarction. A report of the American College of Cardiology/American Heart Association Task Force on Assessment of Diagnostic and Therapeutic Cardiovascular Procedures (Subcommittee to Develop Guidelines for the Early Management of Patients with Acute Myocardial Infarction). J Am Coll Cardiol 1990; 16(2): 249-292.
2. Baenkler HW, Schafer D. Abnormal eicosanoid-pattern of peripheral white-blood cells in gastro-intestinal cancer. J Physiol Pharmacol 2005; 56(Suppl 5): 119-128.
3. Hirschberg VGS. Mitteilung über einen Fall von Nebenwirkungen des Aspirin. Dtsch Med Wochenschr 1902; 28416-28417.
4. Szczeklik A, Sanak M, Nizankowska-Mogilnicka E, Kielbasa B. Aspirin intolerance and the cyclooxygenase-leukotriene pathways. Curr Opin Pulm Med 2004; 10(1): 51-56.
5. Schafer D, Lindenthal U, Wagner M, Bolcskei PL, Baenkler HW. Effect of prostaglandin E2 on eicosanoid release by human bronchial biopsy specimens from normal and inflamed mucosa. Thorax 1996; 51(9): 919-923.
6. Schafer D, Schmid M, Gode UC, Baenkler HW. Dynamics of eicosanoids in peripheral blood cells during bronchial provocation in aspirin-intolerant asthmatics. Eur Respir J 1999; 13(3): 638-646.
7. Schafer D, Baenkler HW. Functional eicosanoid test and typing (FET) of peripheral blood cells in eicosanoids related diseases. J Physiol Pharmacol 2005; 56 (Suppl 5): 103-118.
8. Choi JH, Park HS, Oh HB, et al. Leukotriene-related gene polymorphisms in ASA-intolerant asthma: an association with a haplotype of 5-lipoxygenase. Hum Genet 2004; 114(4): 337-344. Epub 2004 Jan 29.
9. Raskovic S, Bogic M, Peric-Popadic A, Arandjelovic S, Jovcic Z, Tomic-Spiric V. The role of prostaglandins in allergic inflammation. Srp Arh Celok Lek 1998; 126 (9-10): 388-393.
10. Szczeklik A, Nizankowska E, Mastalerz L, Bochenek G. Myocardial ischemia possibly mediated by cysteinyl leukotrienes. J Allergy Clin Immunol 2002; 109(3): 572-573
11. McDonald JW, Ali M. Recovery of cyclooxygenase activity after aspirin in populations of platelets separated on stractan density gradients. Prostaglandins Leukot Med 1983; 12(3): 245-252.
12. Ferrari E, Benhamou M, Cerboni P, Marcel B. Coronary syndromes following aspirin withdrawal: a special risk for late stent thrombosis. J Am Coll Cardiol 2005; 45(3): 456-459.
13. Aberer W, Bircher A, Romano A, et al. Drug provocation testing in the diagnosis of drug hypersensitivity reactions: general considerations. Allergy 2003; 58(9): 854-863.
14. Okuda Y, Hattori H, Takashima T, et al. Basophil histamine release by platelet-activating factor in aspirin-sensitive subjects with asthma. J Allergy Clin Immunol 1990; 86(4 Pt 1): 548-553.
15. Pearson DJ, Suarez-Mendez VJ. Abnormal platelet hydrogen peroxide metabolism in aspirin hypersensitivity. Clin Exp Allergy 1990; 20(2): 157-163.
16. Oosaki R, Mizushima Y, Mita H, Shida T, Akiyama K, Kobayashi M. Urinary leukotriene E4 and 11-dehydrothromboxane B2 in patients with aspirin-sensitive asthma. Allergy 1997; 52(4): 470-473.
17. May A, Weber A, Gall H, Kaufmann R, Zollner T. M. Means of increasing sensitivity of an in vitro diagnostic test for aspirin intolerance. Clin Exp Allergy 1999; 29(10): 1402-1411.
18. Palgan K, Dziedziczko A. Role of neurotrophin and neuropeptides in bronchial asthma. Pol Merkuriusz Lek 2004; 16(92): 101-103.
19. Harada S, Horikawa T, Ashida M, Kamo T, Nishioka E, Ichihashi M. Aspirin enhances the induction of type I allergic symptoms when combined with food and exercise in patients with food-dependent exercise-induced anaphylaxis. Br J Dermatol 2001; 145(2): 336-339.
20. Schäfer D. Testing and typing of eicosanoid-patterns. J Physiol Pharmacol 2006; 57 (Suppl 12): 47-64.